Insiders AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
5.68 ^USD	+0.35%		0.00%	-27.55%

May. 21	AngioDynamics Obtains CE Mark Approval in Europe for AlphaVac F18 System	MT
May. 06	AngioDynamics, Inc. Announces Results from the Acute Pulmonary Embolism Extraction Trial with the Alphavac System (APEX-AV)	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Angiodynamics, Inc. Announces Board Changes	Feb. 13	CI
AngioDynamics, Inc. Announces Dennis Meteny to Retire as A Member of the Board of Directors, Member of the Compensation Committee and Chair of the Audit Committee, Effective January 31, 2024	Jan. 22	CI
David D. Helsel to Leave AngioDynamics, Inc. as Senior Vice President of Global Operations and R&D, Effective January 12, 2024	Jan. 05	CI
AngioDynamics, Inc. Announces Addition of Lorinda Burgess to Board of Directors	23-07-24	CI
AngioDynamics, Inc. Announces Board Changes	23-02-27	CI
Insider Buy: Angiodynamics	22-10-11	MT
Insider Sell: Angiodynamics	22-08-01	MT
Insider Buy: AngioDynamics	22-01-12	MT
Insider Sell: Angiodynamics	21-10-18	MT
AngioDynamics, Inc. Announces Management Changes	21-02-01	CI
Insider Trends: AngioDynamics Insider Extends 90-Day Selling Trend	21-01-21	MT
Kevin Gould Intends to Retire from His Position as Director on the Board of Directors of AngioDyanmics	20-08-14	CI
AngioDynamics, Inc. Appoints Stephen Trowbridge as Executive Vice President and Chief Financial Officer	20-02-06	CI
AngioDynamics, Inc. Announces Management Changes	19-10-22	CI
AngioDynamics, Inc. Approves Appointment of Michael E. Tarnoff as Class I Director	19-10-18	CI
Jeffrey Gold Not to Stand for Reelection as Board of Directors of AngioDynamics, Inc	19-08-16	CI
AngioDynamics, Inc. Appoints Karen Licitra as a Class III Director and to Compensation Committee	19-07-19	CI
AngioDynamics, Inc. Announces Resignation of Robert A. Simpson as Senior Vice President and General Manager for Vascular Interventions and Therapies, Effective August 31, 2019	19-06-06	CI
AngioDynamics Inc. Announces Board Appointments	16-11-09	CI
Mark Stephens to Leave AngioDynamics Inc. as Senior Vice President, Administration, Effective September 23, 2016	16-09-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Insiders

Filters